d1e30690_dic_NECT___Inclusion_completed__Cancer_type
[Title] A Phase 1b/2 study of docetaxel with or without buparlisib as second line therapy for patients with advanced or metastatic squamous non-small cell lung cancer [Country] SE [Cancer type] 
Lung cancer
Nordic NECT - Inclusion completed
Cancer type